BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 38035647)

  • 1. Effectiveness and safety of short-term anticoagulant regimens after left atrial appendage occlusion: A systematic review and meta-analysis.
    Zhou Q; Liu X; Yang X; Huang XH; Wu YZ; Tao YY; Wei M
    Thromb Res; 2024 Jan; 233():88-98. PubMed ID: 38035647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term antiplatelet versus anticoagulant therapy after left atrial appendage closure: a systematic review and meta-analysis.
    Zhou Q; Liu X; Gu ZC; Yang X; Huang XH; Wu YZ; Tao YY; Wei M
    J Thromb Thrombolysis; 2024 Feb; 57(2):194-203. PubMed ID: 38180590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of device-related thrombosis following short-term oral anticoagulation with low-dose dabigatran versus warfarin after Watchman left atrial appendage occlusion.
    Ge H; Zhang C; Qiao ZQ; Hao ZY; Li Z; Gu ZC; Jiang LS; He B; Pu J
    Sci Prog; 2022; 105(3):368504221113194. PubMed ID: 35849447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Outcomes of Left Atrial Appendage Occlusion Versus Switch of Direct Oral Antcoagulant in Atrial Fibrillation: A Territory-Wide Retrospective Analysis.
    Ng AK; Ng PY; Ip A; Fung RC; Chui SF; Siu CW; Yan BP
    J Am Heart Assoc; 2023 Oct; 12(20):e029421. PubMed ID: 37804191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DAPT Is Comparable to OAC Following LAAC With WATCHMAN FLX: A National Registry Analysis.
    Coylewright M; Holmes DR; Kapadia SR; Hsu JC; Gibson DN; Freeman JV; Yeh RW; Piccini JP; Price MJ; Allocco DJ; Nair DG
    JACC Cardiovasc Interv; 2023 Nov; 16(22):2708-2718. PubMed ID: 37943200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of different anticoagulation regimens after left atrial appendage occlusion.
    Li W; Gao R; Zhao J; Ren Y; Chen G; Zhu J; Jin K; Zhu L; Ruan Z
    Ann Palliat Med; 2022 Jan; 11(1):201-209. PubMed ID: 35144411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct Oral Anticoagulant Versus Warfarin After Left Atrial Appendage Closure With WATCHMAN: Updated Systematic Review and Meta-analysis.
    Tan BE; Wong PY; Lee JZ; Tan NY; Rao M; Cheung JW
    Curr Probl Cardiol; 2022 Nov; 47(11):101335. PubMed ID: 35872052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of left atrial appendage occlusion versus direct oral anticoagulation in patients with atrial fibrillation and prior ischemic stroke: A propensity-score matched study.
    Korsholm K; Valentin JB; Damgaard D; Diener HC; Camm AJ; Landmesser U; Hildick-Smith D; Johnsen SP; Nielsen-Kudsk JE
    Int J Cardiol; 2022 Sep; 363():56-63. PubMed ID: 35780932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network Meta-Analysis of Initial Antithrombotic Regimens After Left Atrial Appendage Occlusion.
    Carvalho PEP; Gewehr DM; Miyawaki IA; Nogueira A; Felix N; Garot P; Darmon A; Mazzone P; Preda A; Nascimento BR; Kubrusly LF; Cardoso R
    J Am Coll Cardiol; 2023 Oct; 82(18):1765-1773. PubMed ID: 37611779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct oral anticoagulants versus percutaneous left atrial appendage occlusion in atrial fibrillation: 5-year outcomes.
    Melillo F; Leo G; Parlati ALM; Gaspardone C; Bellini B; Della Bella P; Montorfano M; Mazzone P; Nemola G; Cozzani G; Stella S; Ancona F; Ingallina G; Salerno A; Cera M; Agricola E; Margonato A; Godino C
    Int J Cardiol; 2023 Oct; 389():131188. PubMed ID: 37453454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
    Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
    J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left Atrial Appendage Occlusion Versus Oral Anticoagulation in Atrial Fibrillation : A Decision Analysis.
    Chew DS; Zhou K; Pokorney SD; Matchar DB; Vemulapalli S; Allen LA; Jackson KP; Samad Z; Patel MR; Freeman JV; Piccini JP
    Ann Intern Med; 2022 Sep; 175(9):1230-1239. PubMed ID: 35969865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-Term Antiplatelet Versus Anticoagulant Therapy After Left Atrial Appendage Occlusion: A Systematic Review and Meta-Analysis.
    Osman M; Busu T; Osman K; Khan SU; Daniels M; Holmes DR; Alkhouli M
    JACC Clin Electrophysiol; 2020 May; 6(5):494-506. PubMed ID: 32439033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic Therapy After Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation.
    Freeman JV; Higgins AY; Wang Y; Du C; Friedman DJ; Daimee UA; Minges KE; Pereira L; Goldsweig AM; Price MJ; Reddy VY; Gibson D; Doshi SK; Varosy PD; Masoudi FA; Curtis JP
    J Am Coll Cardiol; 2022 May; 79(18):1785-1798. PubMed ID: 35512858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latest outcomes of transcatheter left atrial appendage closure devices and direct oral anticoagulant therapy in patients with atrial fibrillation over the past 5 years: a systematic review and meta-analysis.
    Takeda K; Tsuboko Y; Iwasaki K
    Cardiovasc Interv Ther; 2022 Oct; 37(4):725-738. PubMed ID: 35098478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left atrial appendage occlusion in recurrent ischaemic stroke, a multicentre experience.
    Galloo X; Carmeliet T; Prihadi EA; Lochy S; Scott B; Verheye S; Schoors D; Vermeersch P
    Acta Clin Belg; 2022 Apr; 77(2):255-260. PubMed ID: 32951514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. True Efficacy of LAA Closure: Patient Outcomes on Long-term Single-Antiplatelet or No Therapy: Insights From the EWOLUTION Registry.
    Paitazoglou C; Bergmann MW; Ince H; Kische S; Romanov A; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Vireca E; Wohlmuth P; Boersma L;
    J Invasive Cardiol; 2022 May; 34(5):E348-E355. PubMed ID: 35501111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left atrial appendage closure: A therapy uniquely suited for specific populations of patients with atrial fibrillation.
    Black-Maier E; Piccini JP; Granger CB
    J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2968-2976. PubMed ID: 31520437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual stroke risk after left atrial appendage closure in patients with prior oral anticoagulation failure.
    Pracoń R; Zieliński K; Bangalore S; Konka M; Kruk M; Kępka C; Trochimiuk P; Dębski M; Przyłuski J; Kaczmarska E; Dzielińska Z; Kurowski A; Witkowski A; Demkow M
    Int J Cardiol; 2022 May; 354():17-21. PubMed ID: 35219744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.